ATRCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。ATR遺伝子サイレンサーは、ATR CRISPR/Cas9ノックアウトプラスミドとATRDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のATRCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
ATR CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
ATR CRISPR/Cas9 KOプラスミド (h) | sc-400335 | h | Gene Knockout | GFP | 0 | ||
ATR HDRプラスミド (h) | sc-400335-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ATR Double Nickaseプラスミド (h) | sc-400335-NIC | h | Gene Knockout | Puromycin | 0 | ||
ATR Double Nickaseプラスミド (h2) | sc-400335-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ATR CRISPR/Cas9 KOプラスミド (m) | sc-434115 | m | Gene Knockout | GFP | 0 | ||
ATR HDRプラスミド (m) | sc-434115-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ATR Double Nickaseプラスミド (m) | sc-434115-NIC | m | Gene Knockout | Puromycin | 0 | ||
ATR Double Nickaseプラスミド (m2) | sc-434115-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
ATR2/CMG2 CRISPR/Cas9 KOプラスミド (h) | sc-414121 | h | Gene Knockout | GFP | 0 | ||
ATR2/CMG2 HDRプラスミド (h) | sc-414121-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ATR2/CMG2 Double Nickaseプラスミド (h) | sc-414121-NIC | h | Gene Knockout | Puromycin | 0 | ||
ATR2/CMG2 Double Nickaseプラスミド (h2) | sc-414121-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ATR2/CMG2 CRISPR/Cas9 KOプラスミド (m) | sc-428139 | m | Gene Knockout | GFP | 0 | ||
ATR2/CMG2 HDRプラスミド (m) | sc-428139-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ATR2/CMG2 Double Nickaseプラスミド (m) | sc-428139-NIC | m | Gene Knockout | Puromycin | 0 | ||
ATR2/CMG2 Double Nickaseプラスミド (m2) | sc-428139-NIC-2 | m | Gene Knockout | Puromycin | 0 |
ATR CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
ATR CRISPR Activationプラスミド (h) | sc-400335-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATR CRISPR Activationプラスミド (h2) | sc-400335-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATR Lentiviral Activation Particles (h) | sc-400335-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATR Lentiviral Activation Particles (h2) | sc-400335-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATR CRISPR Activationプラスミド (m) | sc-434115-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATR CRISPR Activationプラスミド (m2) | sc-434115-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATR Lentiviral Activation Particles (m) | sc-434115-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATR Lentiviral Activation Particles (m2) | sc-434115-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATR2/CMG2 CRISPR Activationプラスミド (h) | sc-414121-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATR2/CMG2 CRISPR Activationプラスミド (h2) | sc-414121-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATR2/CMG2 Lentiviral Activation Particles (h) | sc-414121-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATR2/CMG2 Lentiviral Activation Particles (h2) | sc-414121-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATR2/CMG2 CRISPR Activationプラスミド (m) | sc-428139-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATR2/CMG2 CRISPR Activationプラスミド (m2) | sc-428139-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATR2/CMG2 Lentiviral Activation Particles (m) | sc-428139-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATR2/CMG2 Lentiviral Activation Particles (m2) | sc-428139-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |